Arteris' revenue projections for both Q1 and FY24 are closely aligned with analyst estimates, indicating a stable financial outlook. This alignment suggests a neutral short-term impact on the stock price, as the market expectations are likely already priced in. The slight variance in FY24 projections compared to estimates does not indicate a significant deviation that would warrant a strong market reaction.